3510. Adulteration   and   misbranding   of   conjugated   estrogens.   U.   S.  v.   1
Bottle    *    *    *.    (F.D.C. No. 31315.    Sample No. 24522-L.)
LIBEL FILED :    July 3, 1951, District of New Jersey.
ALLEGED SHIPMENT :    On or about December 21, 1950, from New York, N. Y.
PRODUCT: 1 1,000-tablet bottle of conjugated estrogens at Bayonne, N, J.
Analysis showed that the product contained a total amount of estrogenic
steroids calculated as 0.66 mg. of sodium estrone sulfate per tablet.
NATURE OF CHARGE: Adulteration, Section 501 (c), the strength of the article
differed from that which it was represented to possess, namely, 1.25 mg. of
estrogens in their naturally occurring water-soluble conjugated form expressed
as sodium estrone sulfate.
Misbranding, Section 502 (a), the label statement "Bach tablet contains
1.25 mg. of estrogens in their naturally occurring water-soluble conjugated
form expressed as sodium estrone sulfate" was false and misleading as applied
to an article which contained in each tablet less than the stated amount of
the total estrogenic steroids calculated as sodium estrone sulfate.
The article was adulterated and misbranded in the above respects while held
for sale after shipment in interstate commerce.
DISPOSITION: August 14, 1951. Default decree of condemnation. The court
ordered that the product be delivered to the Federal Security Agency.